Dunsire Deborah 4
4 · Ultragenyx Pharmaceutical Inc. · Filed Jun 28, 2022
Insider Transaction Report
Form 4
Dunsire Deborah
Director
Transactions
- Award
Common Stock
2022-06-24+3,300→ 15,870 total - Award
Stock Option (Right to Buy)
2022-06-24+6,245→ 6,245 totalExercise: $60.57Exp: 2032-06-24→ Common Stock (6,245 underlying)
Footnotes (2)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.
- [F2]The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2023.